Breaking News, Collaborations & Alliances

EUROAPI Expands Collaboration with Sanofi

Will support Sanofi’s mRNA vaccine platform with the development of lipid nanoparticles.

Author Image

By: Charlie Sternberg

Associate Editor

EUROAPI has expanded its collaboration with Sanofi under the umbrella of their Master Agreement for Development and GMP Manufacturing Services (DSA), dated October 1, 2021, to support Sanofi’s mRNA vaccine platform with the development of lipid nanoparticles.   As part of this collaboration, EUROAPI will develop and optimize innovative chemical synthesis routes and manufacture GMP (Good Manufacturing Practices) batches for several second-generation cationic lipids through its Contract Developm...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters